Cheng‐Ying Chiu

658 total citations
11 papers, 535 citations indexed

About

Cheng‐Ying Chiu is a scholar working on Nutrition and Dietetics, Biochemistry and Epidemiology. According to data from OpenAlex, Cheng‐Ying Chiu has authored 11 papers receiving a total of 535 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Nutrition and Dietetics, 5 papers in Biochemistry and 4 papers in Epidemiology. Recurrent topics in Cheng‐Ying Chiu's work include Fatty Acid Research and Health (6 papers), Eicosanoids and Hypertension Pharmacology (5 papers) and Pneumonia and Respiratory Infections (3 papers). Cheng‐Ying Chiu is often cited by papers focused on Fatty Acid Research and Health (6 papers), Eicosanoids and Hypertension Pharmacology (5 papers) and Pneumonia and Respiratory Infections (3 papers). Cheng‐Ying Chiu collaborates with scholars based in Germany and United States. Cheng‐Ying Chiu's co-authors include Karsten H. Weylandt, Bertram Wiedenmann, Michael Rothe, Jing X. Kang, Andréas Fischer, Nadine Rohwer, Joel I. Ward, Nils Helge Schebb, Constance M. Vadheim and Susan Partridge and has published in prestigious journals such as PLoS ONE, The FASEB Journal and The Journal of Infectious Diseases.

In The Last Decade

Cheng‐Ying Chiu

11 papers receiving 530 citations

Peers

Cheng‐Ying Chiu
Iram Hassan United States
H. J. Kramer Germany
Marian Bulthuis Netherlands
Darla Shores United States
Siraj I. Mufti United States
Cynthia E. Seidman United States
Lorraine M. Leader United States
Cheng‐Ying Chiu
Citations per year, relative to Cheng‐Ying Chiu Cheng‐Ying Chiu (= 1×) peers Christian Hudert

Countries citing papers authored by Cheng‐Ying Chiu

Since Specialization
Citations

This map shows the geographic impact of Cheng‐Ying Chiu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cheng‐Ying Chiu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cheng‐Ying Chiu more than expected).

Fields of papers citing papers by Cheng‐Ying Chiu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Cheng‐Ying Chiu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cheng‐Ying Chiu. The network helps show where Cheng‐Ying Chiu may publish in the future.

Co-authorship network of co-authors of Cheng‐Ying Chiu

This figure shows the co-authorship network connecting the top 25 collaborators of Cheng‐Ying Chiu. A scholar is included among the top collaborators of Cheng‐Ying Chiu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Cheng‐Ying Chiu. Cheng‐Ying Chiu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Rohwer, Nadine, Cheng‐Ying Chiu, Dan Huang, et al.. (2021). Omega‐3 fatty acids protect from colitis via an Alox15‐derived eicosanoid. The FASEB Journal. 35(4). e21491–e21491. 23 indexed citations
2.
Chiu, Cheng‐Ying, et al.. (2018). Percutaneous biventricular Impella support in therapy-refractory cardiogenic shock. Heart & Lung. 47(3). 250–252. 13 indexed citations
3.
Chiu, Cheng‐Ying, Dagmar Heydeck, Nadine Rohwer, et al.. (2018). Female mice carrying a defective Alox15 gene are protected from experimental colitis via sustained maintenance of the intestinal epithelial barrier function. Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids. 1863(8). 866–880. 24 indexed citations
4.
Ostermann, Annika I., Patrick Waindok, Cheng‐Ying Chiu, et al.. (2017). Modulation of the endogenous omega-3 fatty acid and oxylipin profile in vivo—A comparison of the fat-1 transgenic mouse with C57BL/6 wildtype mice on an omega-3 fatty acid enriched diet. PLoS ONE. 12(9). e0184470–e0184470. 33 indexed citations
6.
Weylandt, Karsten H., et al.. (2012). Omega-3 fatty acids and their lipid mediators: Towards an understanding of resolvin and protectin formation. Prostaglandins & Other Lipid Mediators. 97(3-4). 73–82. 205 indexed citations
7.
Chiu, Cheng‐Ying, Nora Huang, Martin Purschke, et al.. (2012). Omega-6 docosapentaenoic acid-derived resolvins and 17-hydroxydocosahexaenoic acid modulate macrophage function and alleviate experimental colitis. Inflammation Research. 61(9). 967–976. 64 indexed citations
9.
Greenberg, David P., et al.. (1994). Immunogenicity of Haemophilus influenzae Type b Tetanus Toxoid Conjugate Vaccine in Young Infants. The Journal of Infectious Diseases. 170(1). 76–81. 47 indexed citations
10.
Jelonek, Marie T., et al.. (1993). Comparison of naturally acquired and vaccine-induced antibodies to Haemophilus influenzae type b capsular polysaccharide. Infection and Immunity. 61(12). 5345–5350. 11 indexed citations
11.
Berkowitz, Carol D., Joel I. Ward, J. Owen Hendley, et al.. (1987). PERSISTENCE OF ANTIBODY (AB) TO HAEMOPHILUS INFLUENZAE TYPE B (HIB) AND RESPONSE TO PRP AND PRP-D BOOS-TER IMMUNIZATION IN CHILDREN INITIALLY IMMUNIZED WITH EITHER VACCINE AT 15 TO 24 MONTHS. Pediatric Research. 21(4). 321A–321A. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026